A Prospective, Randomized Trial Comparing the Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing
This is a prospective, multicentre, randomized trial to study therapeutic drug monitoring
(TDM) of voriconazole among patients with an invasive mould infection (IMI). The primary
objective of this study will be to assess the effect of prospective voriconazole TDM on the
composite of adverse events (AE) and clinical response.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society